Why Partner?

A Unique Opportunity to Strengthen Existing Relationships & Form New Connections Within the LNP & Nanoparticles Space

We partner with cutting-edge service providers with capabilities in LNP formulation, lipid chemistry, nanoparticle characterization, drug delivery optimization, AI-driven screening, and CMC development to support biotech and pharmaceutical innovators in advancing extra-hepatic lipid-based delivery systems. Our mission is to unite the industry to overcome key challenges and unlock the full potential of LNP technology for nucleic acid and gene therapies.

If you offer relevant capabilities and are looking to collaborate with key decision-makers in the nanoparticle space, contact us to promote your services and solutions through a bespoke commercial package.

Raise Brand Awareness & Generate Commercial Collaborations

Maximize your commercial opportunities with 7+ hours of dedicated networking with VPs, Directors, and Heads of Non-Viral Delivery, Formulation, Lipid Chemistry, and CMC

Meet & Network with Industry Pioneers

Showcase your brand to both industry leaders and rising disruptors, including AstraZeneca, Novo Nordisk, Takeda, Feldan Therapeutics, Corti Therapeutics, and many more

Benefit from Market Intelligence

Expand your networking horizons by engaging with 80+ experts over 3 days of data-driven discussions, case-study presentations, and interactive panels to align your solutions with industry needs.

Who Will You Meet?

HW250203 59429 4th Next Gen Lipid-Based Nanoparticle Delivery Summit brochure 5

*Taken from the previous editions of the Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit

Next Steps

If you have expertise in this space and would like to align your brand within the Lipid Nanoparticle Delivery space, contact us to promote your capabilities through a bespoke commercial package.

Screenshot 2025-02-06 114408

Jack Marcus

Senior Partnerships Director
Tel: (+1) 6174554188

Email: sponsor@hansonwade.com